SPAIN |MC |EUR
|Public Float||14.21M||P/E Ratio||9.48|
|% Short of Float||-||Dividend (Yield)||0.60 (0.01%)|
|Held by Insiders||26.41%||Ex-Dividend Date||Apr 28, 2021|
|Held by Institutions||11.20%||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Jun 21||Mar 21||Dec 20|
|Jan 21, 2022||€56.50||€57.16||€55.38||€55.88||-3.39%||104.05K|
Pharma mar, s.a is expected to report earnings on May 03 ,2022.
View More Details on Pharma mar, s.a's 'Earnings' Section
Pharma mar, s.a trades on the Madrid stock market in Spain under the ticker symbol "PHM". Pharma mar, s.a’s stock symbol can also be displayed as "BME:PHM".
Pharma mar, s.a (BME:PHM) is owned by 11.20% institutional shareholders and by 26.41% insiders. The rest is owned by the public.
Explore More Details on Pharma mar, s.a's “Ownership” Section
Pharma mar, s.a's key executive team includes the following managers:
Pharma mar, s.a (BME:PHM) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Pharma mar, s.a is 443.
Pharma mar, s.a (BME:PHM) is headquartered in Spain.
Pharma mar, s.a’s mailing address is Avenida de los Reyes, 1, Madrid, Spain, 28770.
The company’s phone number is 34 91 846 60 00.